Evidence map›Paper›PMID 37936473›Full record

ReviewCurrent pharmaceutical biotechnology2024

Enhancement in Biological Availability of Vitamins by Nano-engineering and its Applications: An Update.

Sadhna Mishra, Shalini Sahani, Shikha Pandhi, Arvind Kumar, Dipendra Kumar Mahato, Pradeep Kumar, Kaustubh Chandrakant Khaire, Ashutosh Rai

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current pharmaceutical biotechnology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sadhna MishraFaculty of Agricultural Sciences, GLA University, Mathura-281406, India.ORCID 0000-0002-1700-2681
Shalini SahaniSchool of Chemical Engineering, Yeungnam University, 280 Daehak-ro, Gyeongsan 38541, South Korea.
Shikha PandhiDepartment of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi-221005, India.
Arvind KumarDepartment of Dairy Science and Food Technology, Institute of Agricultural Sciences, Banaras Hindu University, Varanasi-221005, India.
Dipendra Kumar MahatoSchool of Energy Science and Engineering, Indian Institute of Technology Guwahati, Guwahati 781039, Assam, India.
Pradeep KumarDepartment of Botany, University of Lucknow, Lucknow, 226007, India.
Kaustubh Chandrakant KhaireCASS Food Research Centre, School of Exercise and Nutrition Sciences, Deakin University, Burwood, VIC 3125, Australia.
Ashutosh RaiDepartment of Basic and Social Sciences, College of Horticulture, Banda University of Agriculture and Technology, Banda-210001, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin nano-engineering has been accomplished by synthesizing various nanostructures to improve their stability, bioavailability, shelf life, and functioning. This review provides a detailed description of recent advances in the art of encapsulation with high efficiency through the use of practical and logistic nano-engineering techniques such as nanofibres, nanogels, nanobeads, nanotubes, nanoparticles, nanoliposomes, and many other nanostructures. To demonstrate the interaction of molecules with nano-forms, the bioavailability of several vitamins such as B, C, E, A, D, and others in the form of nanostructures is explored. This review will provide a thorough understanding of how to improve bioavailability and nanostructure selection to extend the utility, shelf life, and structural stability of vitamins. While nanoencapsulation can improve vitamin stability and distribution, the materials employed in nanotechnologies may offer concerns if they are not sufficiently tested for safety. If nanoparticles are not adequately designed and evaluated, they may cause inflammation, oxidative stress, or other unwanted effects. Researchers and makers of nanomaterials and medication delivery systems should adhere to established rules and regulations. Furthermore, long-term studies are required to monitor any negative consequences that may result from the use of nanostructure.

Indexed as

Biological AvailabilityNanostructuresNanotechnologyVitaminsAnimalsDrug Delivery SystemsHumansVitaminsbioactive substituentsbioavailabilityencapsulationlipid matrix.Nanoengineeringsupercritical fluidsvitamins

Identifiers

PMID37936473

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.